Pasithea Therapeutics Corp. · NASDAQ:KTTA
Coastlands Capital LP reported a 11.48% stake in Pasithea Therapeutics Corp. (Schedule 13G/A)
Event Apr 9, 2026 · Filed Jul 1, 2026
Coastlands Capital LP reported a 11.48% stake in Pasithea Therapeutics Corp., 3,835,035 shares, as a passive investor on Apr 9, 2026. Filed Jul 1, 2026 (Schedule 13G/A).
- Stake
- 11.48%
- Shares
- 3,835,035
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 5 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Coastlands Capital LP | 11.48% | 3,835,035 |
| Coastlands Capital Partners LP | 11.48% | 3,835,035 |
| Coastlands Capital GP LLC | 11.48% | 3,835,035 |
| Coastlands Capital LLC | 11.48% | 3,835,035 |
| Matthew D. Perry | 11.48% | 3,835,035 |
Source
Related
- Pasithea Therapeutics Corp.
- Coastlands Capital LP
- Pasithea Therapeutics Corp. shareholders
- Schedule 13G · Coastlands Capital LP · Feb 27, 2026
- Schedule 13G/A · Vivo Opportunity, LLC · Aug 14, 2026
- Schedule 13G/A · Opaleye Management Inc. · Jul 31, 2026
- Schedule 13G · Stonepine Capital Management, LLC · Jun 23, 2026
- Form 4 · Coastlands Capital LP · Jun 22, 2026
- Schedule 13G/A · Ameriprise Financial Inc · May 15, 2026